The system for laboratory control of oral anticoagulant therapy using the British comparative thromboplastin
Thomson, J.M.; Chart, I.S.
Journal of Medical Laboratory Technology 27(2): 207-212
1970
ISSN/ISBN: 0368-3109 PMID: 5431717 Document Number: 30374
Document emailed within 1 workday
Related Documents
Hummel, L. 1988: Problems of the laboratory control of oral anticoagulant treatment Folia Haematologica 115(4): 529-531Brink, S.; Cloete, H.; Roberts, R.; Holm, W. 1976: Laboratory standardization and quality control in anticoagulant therapy South African Medical Journal 50(7): 205-208
Syrjälä, M. 1994: Thromboplastin time, INR reporting and recommendations for anticoagulant therapy Duodecim; Laaketieteellinen Aikakauskirja 110(2): 171-172
van den Besselaar, A.M. 1990: Recommended method for reporting therapeutic control of oral anticoagulant therapy. Control of Anticoagulation Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis Thrombosis and Haemostasis 63(2): 316-317
Heene, D.L. 1974: Control of oral anticoagulant therapy using the Hepato-Quick-test Die Medizinische Welt 25(39): 1529-1531
Pattacini, C.; Manotti, C.; Pini, M.; Quintavalla, R.; Dettori, A.G. 1994: A comparative study on the quality of oral anticoagulant therapy (warfarin versus acenocoumarol) Thrombosis and Haemostasis 71(2): 188-191
Palareti, G. 1996: Anticoagulant therapy in patients with atrial fibrillation: the experience of the Centers of Surveillance. Study group of the "Italian Study on Complications of Oral Anticoagulant Therapy" (ISCOAT) Annali Italiani di Medicina Interna: Organo Ufficiale Della Societa Italiana di Medicina Interna 11(Suppl 2): 18s-20s
Lämmle, B.; Furlan, M.; Sulzer, I. 1989: Comparison of a sensitive rabbit brain thromboplastin and a human placenta thromboplastin for thromboplastin time determination Schweizerische Medizinische Wochenschrift 119(6): 178-183
Amián, A.; Rodríguez, J.N.; Muñiz, R.; Diéguez, J.C.; Moreno, M.V.; Quesada, J.A.; Cañavate, M.; Fernández-Jurado, A.; Martino, M.L.; Prados, D. 1996: Comparative study of the stability of oral anticoagulant treatments (warfarin vs acenocoumarol) Sangre 41(1): 9-11
Sellers, E.M.; Koch-Weser, J. 1972: Oral anticoagulant therapy Canadian Medical Association Journal 106(4): 302 Passim
Lechner, K.; Korninger, C.; Kyrle, P.; Geissler, K.; Niessner, H.; Pabinger, I.; Panzer, S.; Gössinger, H.; Bettelheim, P.; Hinterberger, W. 1987: Oral anticoagulant therapy--renaissance of an old therapy? Wiener Klinische Wochenschrift 99(7): 203-210
Holcenberg, J.S.; Veltkamp, J.J. 1970: Drug therapy. V. Oral anticoagulant therapy Northwest Medicine 69(6): 421-424
Thornes, R.D. 1974: Oral anticoagulant therapy of human cancer Journal of Medicine 5(1): 83-91
Blinder, D.; Martinowitz, U.; Ardekian, L.; Peleg, M.; Taicher, S. 1996: Oral surgical procedures during anticoagulant therapy Harefuah 130(10): 681
Vermeer, C. 1982: Side effects of oral anticoagulant therapy? Nederlands Tijdschrift Voor Geneeskunde 126(52): 2394
Miale, J.B. 1979: Prothrombin time standardization report of the expert panel on oral anticoagulant control: a minority opinion Thrombosis and Haemostasis 42(4): 1132-1134
Birger, A.; Engelberg, I. 1986: Rare side-effects of oral anticoagulant therapy Harefuah 111(5-6): 120-122
Kyrle, P.A.; Brockmeier, J.; Weltermann, A.; Eichinger, S.; Speiser, W.; Lechner, K.; Eichler, H.G. 1997: Inhibition rather than enhancement of hemostatic system activation during initiation of oral anticoagulant treatment Thrombosis and Haemostasis 77(4): 685-689
Tripodi, A.; Arbini, A.A.; Chantarangkul, V.; Bettega, D.; Mannucci, P.M. 1993: Are capillary whole blood coagulation monitors suitable for the control of oral anticoagulant treatment by the international normalized ratio? Thrombosis and Haemostasis 70(6): 921-924
Cauli, C.; Barcellona, D.; Marongiu, F. 2003: Oral anticoagulant therapy in the primary and secondary prophylaxis of stroke Italian Heart Journal: Official Journal of the Italian Federation of Cardiology 4(11): 755-767